Return On Equity in % of Predictive Oncology Inc. from 2011 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Predictive Oncology Inc. quarterly/annual Return On Equity history and change rate from 2011 to Q3 2025.
  • Predictive Oncology Inc. Return On Equity for the quarter ending September 30, 2025 was 425 %.
  • Predictive Oncology Inc. annual Return On Equity for 2024 was -511 %, a 253% decline from 2023.
  • Predictive Oncology Inc. annual Return On Equity for 2023 was -145 %, a 71.5% decline from 2022.
  • Predictive Oncology Inc. annual Return On Equity for 2022 was -84.3 %, a 89.5% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Predictive Oncology Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 425 +711 Jul 1, 2025 Sep 30, 2025
Q2 2025 112K +112K Apr 1, 2025 Jun 30, 2025
Q1 2025 -762 -618 -427% Jan 1, 2025 Mar 31, 2025
Q4 2024 -511 -366 -253% Oct 1, 2024 Dec 31, 2024
Q3 2024 -287 -139 -94.5% Jul 1, 2024 Sep 30, 2024
Q2 2024 -189 -73.9 -64.4% Apr 1, 2024 Jun 30, 2024
Q1 2024 -145 -25.1 -21% Jan 1, 2024 Mar 31, 2024
Q4 2023 -145 -60.3 -71.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -147 -74.6 -102% Jul 1, 2023 Sep 30, 2023
Q2 2023 -115 -46.9 -69% Apr 1, 2023 Jun 30, 2023
Q1 2023 -120 -76.6 -178% Jan 1, 2023 Mar 31, 2023
Q4 2022 -84.3 -39.8 -89.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 -72.8 -5.56 -8.27% Jul 1, 2022 Sep 30, 2022
Q2 2022 -67.9 +25.8 +27.5% Apr 1, 2022 Jun 30, 2022
Q1 2022 -42.9 +120 +73.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 -44.5 +236 +84.1% Oct 1, 2021 Dec 31, 2021
Q3 2021 -67.2 +179 +72.6% Jul 1, 2021 Sep 30, 2021
Q2 2021 -93.7 +96.5 +50.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 -163 -34.8 -27.3% Jan 1, 2021 Mar 31, 2021
Q4 2020 -280 -138 -96.3% Oct 1, 2020 Dec 31, 2020
Q3 2020 -246 Jul 1, 2020 Sep 30, 2020
Q2 2020 -190 Apr 1, 2020 Jun 30, 2020
Q1 2020 -128 Jan 1, 2020 Mar 31, 2020
Q4 2019 -143 Oct 1, 2019 Dec 31, 2019
Q2 2015 93 -315 -77.2% Apr 1, 2015 Jun 30, 2015
Q1 2015 120 -253 -67.8% Jan 1, 2015 Mar 31, 2015
Q4 2014 192 -158 -45.1% Oct 1, 2014 Dec 31, 2014
Q3 2014 222 -109 -32.9% Jul 1, 2014 Sep 30, 2014
Q2 2014 408 +143 +54% Apr 1, 2014 Jun 30, 2014
Q1 2014 373 +41.6 +12.6% Jan 1, 2014 Mar 31, 2014
Q4 2013 350 +73.5 +26.6% Oct 1, 2013 Dec 31, 2013
Q3 2013 331 Jul 1, 2013 Sep 30, 2013
Q2 2013 265 Apr 1, 2013 Jun 30, 2013
Q1 2013 331 Jan 1, 2013 Mar 31, 2013
Q4 2012 276 Oct 1, 2012 Dec 31, 2012

Predictive Oncology Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -511 -366 -253% Jan 1, 2024 Dec 31, 2024
2023 -145 -60.3 -71.5% Jan 1, 2023 Dec 31, 2023
2022 -84.3 -39.8 -89.5% Jan 1, 2022 Dec 31, 2022
2021 -44.5 +236 +84.1% Jan 1, 2021 Dec 31, 2021
2020 -280 -138 -96.3% Jan 1, 2020 Dec 31, 2020
2019 -143 +203 +58.7% Jan 1, 2019 Dec 31, 2019
2018 -346 Jan 1, 2018 Dec 31, 2018
2014 192 -158 -45.1% Jan 1, 2014 Dec 31, 2014
2013 350 +73.5 +26.6% Jan 1, 2013 Dec 31, 2013
2012 276 +88.3 +47% Jan 1, 2012 Dec 31, 2012
2011 188 Jan 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.